Kelly Molpus, MD
Gynecologic Oncology · Daytona Beach, FLNPI 1699877506
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,092 of the $1,478 with a category attached, or 73.9%. Intuitive Surgical accounts for 70.7% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2021 at $710 and has fallen 71.3% since, to $203 in 2025. That places this record below the midpoint for gynecologic oncology clinicians in FL, where the typical reported total is $2,602.
Across 38 payments — averaging $38.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$1K
- Merck$104
- Novartis$89
- Johnson & Johnson$73
- AstraZeneca$43
- Tesaro, Inc.$29
- plus $96 from 5 others
What the payments were for
- Travel & lodging$18613%
- Food & beverage$1,09274%
- Gifts$20014%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 16 | $1,045 |
| Merck | 6 | $104 |
| Novartis | 5 | $89 |
| Johnson & Johnson | 3 | $73 |
| AstraZeneca(2 entities) | 2 | $43 |
| Tesaro, Inc. | 1 | $29 |
| Asensus Surgical, Inc. | 1 | $28 |
| Bayer | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Tempus AI, Inc | 1 | $17 |
| Incyte Corporation | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,478 in reported general payments places this provider in the 40th percentile of 117 gynecologic oncology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 24 | $420 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 42 | $308 |
| Ondansetron Hcl | 27 | $226 |
| Anastrozole | 15 | $120 |
| Tramadol Hcl | 13 | $101 |
| Ondansetron OdtOndansetron | 11 | $52 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in Daytona Beach
- Bradley MonkWest Palm Beach$2.5M
- Martin MartinoJacksonville$957K
- Brian SlomovitzFort Lauderdale$519K
- Ricardo EstapeMiami$457K
- Robert HollowayOrlando$432K
- Shelly SewardOrlando$349K
- Edward GrendysFort Myers$341K
- Jonathan BlackMiramar$329K
- Nathalie McKenzieOrlando$223K
- John McBroomNaples$187K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.